|
1
|
Promoter hypermethylation profile of kidney cancer.
|
Clin Cancer Res
|
2004
|
2.02
|
|
2
|
Global reactivation of epigenetically silenced genes in prostate cancer.
|
Cancer Prev Res (Phila)
|
2010
|
1.66
|
|
3
|
Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients.
|
Cancer Res
|
2004
|
1.66
|
|
4
|
Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
|
Clin Cancer Res
|
2004
|
1.62
|
|
5
|
Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis.
|
Cancer Res
|
2003
|
1.59
|
|
6
|
Signaling pathways in renal cell carcinoma.
|
Cancer Biol Ther
|
2010
|
1.58
|
|
7
|
Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
|
Cancer Res
|
2006
|
1.49
|
|
8
|
Telomerase is frequently activated in tumors with microsatellite instability.
|
Cancer Biol Ther
|
2004
|
1.47
|
|
9
|
Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation.
|
Clin Cancer Res
|
2004
|
1.31
|
|
10
|
Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.
|
Cancer Res
|
2011
|
1.29
|
|
11
|
Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.
|
Clin Cancer Res
|
2004
|
1.22
|
|
12
|
Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.
|
Cancer Res
|
2007
|
1.21
|
|
13
|
Promoter methylation and the detection of breast cancer.
|
Cancer Causes Control
|
2009
|
1.18
|
|
14
|
Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.
|
Cancer Res
|
2003
|
1.13
|
|
15
|
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
|
Cancer Res
|
2008
|
1.11
|
|
16
|
LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer.
|
J Biol Chem
|
2002
|
1.10
|
|
17
|
Reduction of Pax9 gene dosage in an allelic series of mouse mutants causes hypodontia and oligodontia.
|
Hum Mol Genet
|
2005
|
1.09
|
|
18
|
ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.
|
Cancer Prev Res (Phila)
|
2011
|
1.03
|
|
19
|
VILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survival.
|
PLoS One
|
2008
|
1.00
|
|
20
|
Reducing number entry errors: solving a widespread, serious problem.
|
J R Soc Interface
|
2010
|
1.00
|
|
21
|
DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study.
|
Cancer Epidemiol
|
2010
|
0.98
|
|
22
|
The genetics of renal oncocytosis: a possible model for neoplastic progression.
|
Cancer Genet Cytogenet
|
2004
|
0.93
|
|
23
|
The effect of interruptions on postcompletion and other procedural errors: an account based on the activation-based goal memory model.
|
J Exp Psychol Appl
|
2008
|
0.92
|
|
24
|
Epigenetics of kidney cancer and bladder cancer.
|
Epigenomics
|
2011
|
0.91
|
|
25
|
Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy.
|
Methods Mol Biol
|
2011
|
0.89
|
|
26
|
Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC.
|
Epigenetics
|
2013
|
0.89
|
|
27
|
Haploinsufficiency of the germ cell-specific nuclear RNA binding protein hnRNP G-T prevents functional spermatogenesis in the mouse.
|
Hum Mol Genet
|
2008
|
0.86
|
|
28
|
Induction of the estrogen receptor by ablation of DNMT1 in ER-negative breast cancer cells.
|
Cancer Biol Ther
|
2003
|
0.84
|
|
29
|
Translational application of epigenetic alterations: ovarian cancer as a model.
|
FEBS Lett
|
2011
|
0.83
|
|
30
|
Molecular genetics and histopathologic features of adult distal nephron tumors.
|
Urology
|
2002
|
0.82
|
|
31
|
The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician.
|
Urol Clin North Am
|
2003
|
0.81
|
|
32
|
Evaluating care pathways for community psychiatry in England: a qualitative study.
|
J Eval Clin Pract
|
2012
|
0.81
|
|
33
|
Genome-wide promoter methylome of small renal masses.
|
PLoS One
|
2013
|
0.80
|
|
34
|
Epigenomics-based diagnostics.
|
Clin Chem
|
2010
|
0.79
|
|
35
|
Characterization of starch from tubers of yam bean (Pachyrhizus ahipa).
|
J Agric Food Chem
|
2002
|
0.77
|
|
36
|
Synergistic interactions between the genetically modified bacterial polysaccharide P2 and carob or konjac mannan.
|
Carbohydr Res
|
2004
|
0.75
|